Michelangelo M. T.
- Country
- Italy
- Department
- Department of Medical Specialties – Unit of Neurology
Research Overview
- Evaluation of NMD670 Efficacy, Safety, and Tolerability in Adult Patients with AChR/MuSK-Ab+ Myasthenia Gravis: A Phase 2b Randomized, Double-Blind, Placebo-Controlled Study
- Evaluation of Gefurulimab (ALXN1720) Efficacy and Safety in Adults with Generalized Myasthenia Gravis: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study
- Phase 2 Randomized, Blinded, Placebo-Controlled Study of DNTH103 in Adults with Generalized Myasthenia Gravis
Data & Insights
Has run more than one trial at 28 of 94 partner sites.
Specializations
Neuromuscular Disorders
This investigator specializes in the treatment and research of generalized myasthenia gravis (gMG), with particular emphasis on novel therapeutic approaches for patients with autoimmune neuromuscular junction disorders.
- Acetylcholine receptor antibody-positive gMG
- Neuromuscular junction pathology
- Autoimmune neurology
Their research encompasses both monotherapy and combination treatment approaches for managing gMG symptoms.
Therapeutic Innovation
The investigator focuses on evaluating emerging targeted biological therapies for neuromuscular conditions, particularly investigating novel compounds for treating generalized myasthenia gravis.
- Complement inhibition therapy
- Novel therapeutic compounds
- Combination treatment strategies
Their work involves assessing multiple therapeutic agents across different mechanisms of action.
Clinical Assessment
Expert in evaluating patient functional outcomes and treatment responses in neuromuscular disorders, with specific focus on measuring daily functioning impacts in gMG patients.
- Quality of life assessment
- Treatment efficacy measures
- Safety and tolerability evaluation
Their research emphasizes comprehensive assessment of both therapeutic efficacy and patient safety.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.